Drug intelligence / Profile preview

Cellchem Ultra Strength Probiotics

Development stage: Unknown
Lead developer: CellChem
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Cellchem Ultra Strength Probiotics is an oral live bacterial supplement distributed by Cellchem Pharmaceuticals, a Canadian pharmaceutical supplier. As a high-potency probiotic formulation, it is designed to support gastrointestinal health by replenishing and maintaining a diverse population of beneficial bacteria within the gut microbiome. The product functions through mechanisms such as competitive inhibition of pathogenic microbes, enhancement of the intestinal epithelial barrier, and modulation of mucosal immunity. It is marketed in Canada as an over-the-counter (OTC) natural health product for individuals seeking to improve digestive wellness and restore microbial balance.

Brand names: Cellchem Ultra Strength Probiotics
Other names: Ultra Strength Probiotics

Beyond the preview

Go deeper on Cellchem Ultra Strength Probiotics.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellchem Ultra Strength Probiotics.

Explore the full profile